SEC Form 4 · accession 0001193125-26-274343
Neuronetics, Inc. · STIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Avinash Amin
Director
Period of report
Jun 15, 2026
Accepted (ET)
Jun 17, 2026 · 4:57 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001227636
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 15, 2026 | J | 2,934 | $0.00 | D | 69,566 | D | |
| Common StockF3 | Jun 15, 2026 | J | 34,932 | $0.00 | D | 34,634 | D | |
| Common StockF4 | Jun 15, 2026 | J | 4,634 | $0.00 | D | 30,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported transactions involved a transfer of shares received by Avinash Amin as director compensation to each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities") as provided for in each fund's respective partnership agreement. Each transfer was made for no consideration.
- F2Represents shares of common stock transferred to Health Partners.
- F3Represents shares of common stock transferred to Cayman Master.
- F4Represents shares of common stock transferred to Select Opportunities.